{'text': 'Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia', 'publisher': {'href': 'https://www.nature.com', 'title': 'Nature.com'}, 'created_at': 'Fri, 05 Sep 2014 07:00:00 GMT', 'description': 'Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia  Nature.com', 'url': 'https://news.google.com/rss/articles/CBMiU0FVX3lxTE50T1cwa1ZjVFphbG5ORUlNLTJZeVV4UUNtMUZvUms1T25sNjlFRmpZRG1EZXdmMEd5blRVbVJacEZndnFXeDc1YjI4N29sbE4wWW0w?oc=5&hl=en-US&gl=US&ceid=US:en'}
